Roger Perlmutter startup raises $350 million
The biotech news stories you need to read, brought to you by The Readout.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Hiya. Once more, a bill has been introduced in Congress to incentivize small molecular drug development by removing what the industry calls the Inflation Reduction Act’s “pill penalty.” Also, a startup run by Merck alum Roger Perlmutter is raising $350 million.
